(Press-News.org)
For decades, scientists have known that motor proteins like kinesin-2 ferry vital cargo along microtubule “highways” inside cells. But how these molecular vehicles identify and bind to the right cargo remained a mystery. The new study provides a key piece of this puzzle by revealing the atomic-level structure of the kinesin-2 tail and its interaction with cargo and adaptor proteins.
This study, led by Professor Nobutaka Hirokawa from Juntendo University with Dr. Masahide Kikkawa from the University of Tokyo, Dr. Xuguang Jiang, a JSPS Postdoctoral Fellow, Dr. Radostin Danev from the University of Tokyo, and Mr. Sotaro Ichinose from Gunma University, was published in Science Advances on October 24, 2025.
Using cryo-electron microscopy and molecular dynamics simulations, the scientists reconstructed the structure of the heterotrimeric kinesin-2 complex (KIF3A/KIF3B/KAP3) bound to the cargo protein, adenomatous polyposis coli (APC). They discovered a unique structural motif in the tail region of KIF3A and KIF3B (termed hook-like adaptor and cargo-binding (HAC) domain) that acts as a molecular “hook,” enabling the motor to assemble its adaptors and recognize cargo with high specificity.
“Our study has uncovered a previously unknown ‘hook-like’ structural element, the HAC domain, in the tail of the motor protein kinesin-2,” said Prof. Hirokawa. “This domain acts as a molecular ‘connector’ that allows the motor to correctly recognize and transport its cargo inside cells.”
The HAC domain consists of a helix–β-hairpin–helix (H-βh-H) motif that forms a scaffold for the adaptor protein KAP3 and the cargo protein APC. The study revealed four distinct binding interfaces between KIF3 and KAP3, with KIF3A playing a dominant role in cargo recognition. The researchers also found that the HAC/KAP3 structure resembles cargo-binding architectures of other motor proteins, such as dynein and kinesin-1, suggesting a shared recognition framework.
“This discovery builds on decades of research from our laboratory, which first identified and characterized the complete family of mammalian kinesin motor proteins in the 1980s and 1990s and later revealed how these molecular ‘vehicles’ move along the cytoskeletal ‘highways’ of the cell,” Prof. Hirokawa said. “While we have long understood how these motors travel, the remaining mystery was how they know what to carry. Our new findings provide the first atomic-level insight into this ‘logistics code’ of cellular transport, the molecular rules that allow each motor to recognize and deliver its specific cargo with remarkable precision.”
The team validated their structural model using cross-linking mass spectrometry, biochemistry, and neuronal cell biology. They showed that the HAC domain binds specifically to the ARM repeat region of APC, a tumor suppressor protein involved in neuronal RNA transport. Notably, KIF3A contributed the majority of the binding energy, while KIF3B played a structural support role.
“Defects in intracellular transport are linked to a variety of human diseases, including neurodegenerative diseases, neurodevelopmental disorders, and ciliopathies,” Prof. Hirokawa said. “Understanding how motor proteins accurately recognize and deliver their cargo provides a molecular basis for developing new diagnostic and therapeutic approaches.”
The study also highlights the potential for drug discovery targeting motor-cargo interactions and the design of artificial transport systems that mimic biological logistics. However, the authors note that some regions of the protein complex remain unresolved due to structural flexibility, and further studies are needed to explore cargo diversity and regulatory mechanisms. This research marks a major step toward decoding the cellular transport system and understanding motor-driven cargo delivery in neurons.
Reference
Authors
Xuguang Jiang1, Radostin Danev1, Sotaro Ichinose2, Baichun Niu1, Sumio Ohtsuki3, Haruaki Yanagisawa1, Satoru Nagatoishi4, Kouhei Tsumoto4, Nobutaka Hirokawa1,5,*, and Masahide Kikkawa1,*
Title of original paper
The hook-like adaptor and cargo-binding (HAC) domain in the kinesin-2 tail enables adaptor assembly and cargo recognition
Journal
Science Advances
DOI
10.1126/sciadv.ady5861
Affiliations
1Department of Cell Biology and Anatomy, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
2Department of Anatomy, Graduate School of Medicine, Gunma University, Gunma, Japan
3Department of Pharmaceutical Microbiology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan
4Department of Bioengineering, School of Engineering, The University of Tokyo, Tokyo, Japan
5Graduate School of Medicine, Juntendo University, Tokyo, Japan
About Professor Nobutaka Hirokawa from Juntendo University
Professor Nobutaka Hirokawa is a leading cell biologist renowned for his pioneering work on intracellular transport and the kinesin superfamily of motor proteins. Based at the Graduate School of Medicine, Juntendo University in Tokyo, Japan, his research has fundamentally shaped our understanding of how molecular motors drive cargo delivery along microtubules within cells. Since the 1980s, Professor Hirokawa’s laboratory has identified and characterized key kinesin family members and elucidated their roles in neuronal development, sensory function, and disease. His work continues to uncover the molecular logistics of life, bridging structural biology with neuroscience and translational medicine.
END
Carbon-supported single-atom catalysts with metal-N moieties are highly promising for lithium–sulfur batteries. They can enhance redox kinetics and suppress the dissolution of lithium polysulfides. However, carbon substrate structure optimization and catalyst coordination environment modulation must be done simultaneously to maximize the potential of these catalysts.
Taking on this challenge, a team of researchers led by two Associate Professors from Chung-Ang University—Seung-Keun Park from the Department of ...
Streptococcus pyogenes or invasive Group A Streptococcus (iGAS) is a major clinical concern around the world, since iGAS infections can quickly escalate into life-threatening conditions such as necrotizing fasciitis, septic shock, and pneumonia. In recent years, scientists have noticed that the prevalence of various pathological strains of iGAS has been evolving. Before the COVID-19 pandemic, the prevalent strain in Western Europe was Emm1. However, in the last five years, a potentially more virulent strain called M1uk has been seen in several European countries. It is not clear whether ...
PRESS EMBARGO! NOT FOR RELEASE UNTIL THURSDAY NOVEMBER 6 AT 12H00 NOON GMT
Three new toad species skip the tadpole phase and give birth to live toadlets
An international team of researchers have identified three new species of enchanting, pustular, tree-dwelling toads from Africa. Their solution for having offspring away from water? Skipping the tadpole phase altogether, and giving birth to live toadlets. The study is published today in the open access scientific journal Vertebrate Zoology.
Most textbooks ...
About The Study: The findings of this study confirm that negative reinforcement is a core mechanism in opioid addiction, which is well established in preclinical research but less represented in treatment. Importantly, it is not limited to the later stages of addiction but is even observed after regular opioid use, potentially contributing to the development of addiction, which may have important implications for the development of more effective preventive and therapeutic interventions.
Corresponding Author: To contact the corresponding author, Karen D. Ersche, PhD, email ke220@cam.ac.uk.
To ...
RODIN - Cell-mediated Sculptable Living Platforms-, is set to revolutionize the field of biomaterials and tissue engineering by shifting the focus from designing materials for cells to empowering cells to design their own environments. The team composed by Professor João Mano at the Associate Laboratory CICECO – Aveiro Institute of Materials from University of Aveiro (Portugal) - The Biomaterials Engineer, Professor Tom Ellis at Imperial College London (UK)- The Synthetic Biologist and Professor Nuno Araújo at Faculty of Sciences, from the University of Lisbon (Portugal)- The Physicist, will combine expertise to rethink how living ...
Diagnosing and treating tumors in real time during endoscopy, with theragnostics: the tumor is identified and characterized with a high-resolution ‘optical biopsy’ and, at the same time, treated with ‘cold plasma’ (that does not involve thermal energy and is therefore much safer). This is the core of ‘MULTIPROBE’, a multicenter project conducted by researchers from the Università Cattolica del Sacro Cuore, campus di Roma, Fondazione Universitaria Policlinico Agostino Gemelli IRCCS, Sapienza Università di Roma, and the University of Limoges, France, which won the prestigious ERC Synergy Grant 2025 research ...
Professors Jun Borras, Esteve Corbera, Ian Scoones and Anna Tsing, working at universities in the Netherlands, Spain, the UK and Denmark, have been awarded an €8.33 million European Research Council (ERC) Synergy Grant for their five-year project, Land and Life in the Anthropocene: Landscape reform (LAND). The project asks a pressing question: How can we learn to live on Earth in new ways?
The innovation of the project is to move from land reform to landscape reform, that is, liveable and justice-based transformations for more-than-human life. LAND starts from the recognition that economies, politics, social ...
A new study led by researchers at the University of Hawai‘i (UH) at Mānoa published today in Nature Communications is the first of its kind to show that waste discharged from deep-sea mining operations in the Pacific’s biodiverse Clarion-Clipperton Zone (CCZ) could disrupt marine life in the midwater “twilight zone” — a vital region 200-1,500 meters below sea level that supports vast communities of zooplankton, tiny animals that serve as the ocean’s basic food building blocks. Specifically, it finds that 53% of all zooplankton and 60% of micronekton, which feed on zooplankton, would be impacted by the discharge, which could ...
BALTIMORE, MD., November 6, 2025--Researchers at the University of Maryland School of Medicine’s Center for Vaccine Development and Global Health (CVD) reported encouraging results from an early phase clinical trial that found an experimental intranasal vaccine triggered a broad immune response against multiple strains of H5N1 “bird flu”. The study, published today in the journal Nature Communications, highlights the potential of mucosal immunization strategies--where vaccines are squirted into the nostrils--to prime immune defenses against diverse influenza strains.
The spread of H5N1 influenza in animals with spillover into human ...
Each year, about 100,000 Americans experience psychosis, a serious condition that disrupts thoughts and perceptions so profoundly that it can distort a person’s sense of reality. Now—just over a year after the first new schizophrenia drug in half a century was approved—a study in Nature Mental Health looks at how patients respond to it, offering early clues for more personalized treatment.
The study, led by Michael Halassa, professor of neuroscience at Tufts University School of Medicine, analyzed electronic medical records from 49 patients hospitalized for schizophrenia, schizoaffective disorder, or bipolar disorder ...